Literature DB >> 7348578

Glycosylated haemoglobin levels in breast cancer patients receiving cytotoxic chemotherapy.

B Cantwell, I F Shirley, J J Fennelly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7348578     DOI: 10.1007/bf01806270

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  6 in total

1.  Quantitation of specific serum glycoproteins in malignancy.

Authors:  S Snyder; G Ashwell
Journal:  Clin Chim Acta       Date:  1971-10       Impact factor: 3.786

2.  Do plasma glycoproteins induce lymphocyte hyporesponsiveness and insulin resistance?

Authors:  J C Davis; L J Hipkin; R Finn; C A St Hill
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

3.  Glycosylated haemoglobins in advanced malignancy.

Authors:  M Koçak; L J Hipkin; J C Davis
Journal:  Eur J Cancer       Date:  1981-01       Impact factor: 9.162

Review 4.  The clinical utility of glycosylated hemoglobin.

Authors:  L Jovanovic; C M Peterson
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

5.  Serum proteins as tumour markers for breast cancer.

Authors:  P Mattison; D H Cove; L Walsh; A Howell; B McConkey; J M Morrison
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

6.  Serum sialic acid and CEA concentrations in human breast cancer.

Authors:  A Hogan-Ryan; J J Fennelly; M Jones; B Cantwell; M J Duffy
Journal:  Br J Cancer       Date:  1980-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.